U.S. Markets close in 4 hrs 28 mins

Bausch Health: Long-Term Promise or Stalled at the Top of the Range?

Bruce Kamich

In his second "Executive Decision" segment of his popular Mad Money program Thursday night, Jim Cramer sat down with Joe Papa, chairman and CEO of Bausch Health Cos. Papa started off by stating that it's the first anniversary of Lumify, BHC's newest treatment for red eyes, and already the product is among the most recommended by doctors and is selling at a $50 million annual run rate. Papa noted that BHC's strength comes from its diversification.